Click for best price
Liver Cirrhosis Therapeutics Drugs Market Size, Share 2024
The global Liver Cirrhosis Therapeutics Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Liver Cirrhosis Therapeutics Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Liver Cirrhosis Therapeutics Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Liver Cirrhosis Therapeutics Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Liver Cirrhosis Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cirrhosis Therapeutics Drugs. This report contains market size and forecasts of Liver Cirrhosis Therapeutics Drugs in global, including the following market information:
- Global Liver Cirrhosis Therapeutics Drugs Market Revenue, 2019-2024, 2024-2029, ($ millions)
- Global Liver Cirrhosis Therapeutics Drugs Market Sales, 2019-2024, 2024-2029, (K Pcs)
- Global top five Liver Cirrhosis Therapeutics Drugs companies in 2023 (%)
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Oral Liver Cirrhosis Therapeutics Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Liver Cirrhosis Therapeutics Drugs include Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, Roche, Bristol-Myers Squibb, Conatus Pharmaceuticals, Gwo Xi Stem Cell Applied Technology and Instituto Grifols, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Liver Cirrhosis Therapeutics Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liver Cirrhosis Therapeutics Drugs Market, by Type, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Liver Cirrhosis Therapeutics Drugs Market Segment Percentages, by Type, 2023 (%)
- Oral Liver Cirrhosis Therapeutics Drugs
- Injection Liver Cirrhosis Therapeutics Drugs
Global Liver Cirrhosis Therapeutics Drugs Market, by Application, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Liver Cirrhosis Therapeutics Drugs Market Segment Percentages, by Application, 2023 (%)
Global Liver Cirrhosis Therapeutics Drugs Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Liver Cirrhosis Therapeutics Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Liver Cirrhosis Therapeutics Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Liver Cirrhosis Therapeutics Drugs revenues share in global market, 2023 (%)
- Key companies Liver Cirrhosis Therapeutics Drugs sales in global market, 2019-2024 (Estimated), (K Pcs)
- Key companies Liver Cirrhosis Therapeutics Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Gilead Sciences
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Roche
- Bristol-Myers Squibb
- Conatus Pharmaceuticals
- Gwo Xi Stem Cell Applied Technology
- Instituto Grifols
- Intercept Pharmaceuticals
- NGM Biopharmaceuticals
- Norgine
- Pharmicell
- Salix Pharmaceuticals
- Stempeutics Research
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liver Cirrhosis Therapeutics Drugs, market overview.
Chapter 2: Global Liver Cirrhosis Therapeutics Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Liver Cirrhosis Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liver Cirrhosis Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Liver Cirrhosis Therapeutics Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Liver Cirrhosis Therapeutics Drugs Market, Global Outlook and Forecast 2024-2031 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
115 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Liver Cirrhosis Therapeutics Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liver Cirrhosis Therapeutics Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liver Cirrhosis Therapeutics Drugs Overall Market Size
2.1 Global Liver Cirrhosis Therapeutics Drugs Market Size: 2022 VS 2031
2.2 Global Liver Cirrhosis Therapeutics Drugs Revenue, Prospects & Forecasts: 2019-2031
2.3 Global Liver Cirrhosis Therapeutics Drugs Sales: 2019-2031
3 Company Landscape
3.1 Top Liver Cirrhosis Therapeutics Drugs Players in Global Market
3.2 Top Global Liver Cirrhosis Therapeutics Drugs Companies Ranked by Revenue
3.3 Global Liver Cirrhosis Therapeutics Drugs Revenue by Companies
3.4 Global Liver Cirrhosis Therapeutics Drugs Sales by Companies
3.5 Global Liver Cirrhosis Therapeutics Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Liver Cirrhosis Therapeutics Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Liver Cirrhosis Therapeutics Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liver Cirrhosis Therapeutics Drugs Players in Global Market
3.8.1 List of Global Tier 1 Liver Cirrhosis Therapeutics Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Liver Cirrhosis Therapeutics Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Liver Cirrhosis Therapeutics Drugs Market Size Markets, 2022 & 2031
4.1.2 Oral Liver Cirrhosis Therapeutics Drugs
4.1.3 Injection Liver Cirrhosis Therapeutics Drugs
4.2 By Type - Global Liver Cirrhosis Therapeutics Drugs Revenue & Forecasts
4.2.1 By Type - Global Liver Cirrhosis Therapeutics Drugs Revenue, 2019-2024
4.2.2 By Type - Global Liver Cirrhosis Therapeutics Drugs Revenue, 2024-2031
4.2.3 By Type - Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share, 2019-2031
4.3 By Type - Global Liver Cirrhosis Therapeutics Drugs Sales & Forecasts
4.3.1 By Type - Global Liver Cirrhosis Therapeutics Drugs Sales, 2019-2024
4.3.2 By Type - Global Liver Cirrhosis Therapeutics Drugs Sales, 2024-2031
4.3.3 By Type - Global Liver Cirrhosis Therapeutics Drugs Sales Market Share, 2019-2031
4.4 By Type - Global Liver Cirrhosis Therapeutics Drugs Price (Manufacturers Selling Prices), 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liver Cirrhosis Therapeutics Drugs Market Size, 2022 & 2031
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Liver Cirrhosis Therapeutics Drugs Revenue & Forecasts
5.2.1 By Application - Global Liver Cirrhosis Therapeutics Drugs Revenue, 2019-2024
5.2.2 By Application - Global Liver Cirrhosis Therapeutics Drugs Revenue, 2024-2031
5.2.3 By Application - Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share, 2019-2031
5.3 By Application - Global Liver Cirrhosis Therapeutics Drugs Sales & Forecasts
5.3.1 By Application - Global Liver Cirrhosis Therapeutics Drugs Sales, 2019-2024
5.3.2 By Application - Global Liver Cirrhosis Therapeutics Drugs Sales, 2024-2031
5.3.3 By Application - Global Liver Cirrhosis Therapeutics Drugs Sales Market Share, 2019-2031
5.4 By Application - Global Liver Cirrhosis Therapeutics Drugs Price (Manufacturers Selling Prices), 2019-2031
6 Sights by Region
6.1 By Region - Global Liver Cirrhosis Therapeutics Drugs Market Size, 2022 & 2031
6.2 By Region - Global Liver Cirrhosis Therapeutics Drugs Revenue & Forecasts
6.2.1 By Region - Global Liver Cirrhosis Therapeutics Drugs Revenue, 2019-2024
6.2.2 By Region - Global Liver Cirrhosis Therapeutics Drugs Revenue, 2024-2031
6.2.3 By Region - Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share, 2019-2031
6.3 By Region - Global Liver Cirrhosis Therapeutics Drugs Sales & Forecasts
6.3.1 By Region - Global Liver Cirrhosis Therapeutics Drugs Sales, 2019-2024
6.3.2 By Region - Global Liver Cirrhosis Therapeutics Drugs Sales, 2024-2031
6.3.3 By Region - Global Liver Cirrhosis Therapeutics Drugs Sales Market Share, 2019-2031
6.4 North America
6.4.1 By Country - North America Liver Cirrhosis Therapeutics Drugs Revenue, 2019-2031
6.4.2 By Country - North America Liver Cirrhosis Therapeutics Drugs Sales, 2019-2031
6.4.3 US Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.4.4 Canada Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.4.5 Mexico Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.5 Europe
6.5.1 By Country - Europe Liver Cirrhosis Therapeutics Drugs Revenue, 2019-2031
6.5.2 By Country - Europe Liver Cirrhosis Therapeutics Drugs Sales, 2019-2031
6.5.3 Germany Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.5.4 France Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.5.5 U.K. Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.5.6 Italy Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.5.7 Russia Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.5.8 Nordic Countries Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.5.9 Benelux Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.6 Asia
6.6.1 By Region - Asia Liver Cirrhosis Therapeutics Drugs Revenue, 2019-2031
6.6.2 By Region - Asia Liver Cirrhosis Therapeutics Drugs Sales, 2019-2031
6.6.3 China Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.6.4 Japan Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.6.5 South Korea Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.6.6 Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.6.7 India Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.7 South America
6.7.1 By Country - South America Liver Cirrhosis Therapeutics Drugs Revenue, 2019-2031
6.7.2 By Country - South America Liver Cirrhosis Therapeutics Drugs Sales, 2019-2031
6.7.3 Brazil Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.7.4 Argentina Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Liver Cirrhosis Therapeutics Drugs Revenue, 2019-2031
6.8.2 By Country - Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales, 2019-2031
6.8.3 Turkey Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.8.4 Israel Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.8.5 Saudi Arabia Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
6.8.6 UAE Liver Cirrhosis Therapeutics Drugs Market Size, 2019-2031
7 Manufacturers & Brands Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Company Summary
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.1.4 Gilead Sciences Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Gilead Sciences Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.3.4 Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.4.4 Merck Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Merck Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.5.4 Roche Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Roche Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.6.4 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Conatus Pharmaceuticals
7.7.1 Conatus Pharmaceuticals Company Summary
7.7.2 Conatus Pharmaceuticals Business Overview
7.7.3 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.7.4 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Conatus Pharmaceuticals Key News & Latest Developments
7.8 Gwo Xi Stem Cell Applied Technology
7.8.1 Gwo Xi Stem Cell Applied Technology Company Summary
7.8.2 Gwo Xi Stem Cell Applied Technology Business Overview
7.8.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.8.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Gwo Xi Stem Cell Applied Technology Key News & Latest Developments
7.9 Instituto Grifols
7.9.1 Instituto Grifols Company Summary
7.9.2 Instituto Grifols Business Overview
7.9.3 Instituto Grifols Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.9.4 Instituto Grifols Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Instituto Grifols Key News & Latest Developments
7.10 Intercept Pharmaceuticals
7.10.1 Intercept Pharmaceuticals Company Summary
7.10.2 Intercept Pharmaceuticals Business Overview
7.10.3 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.10.4 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Intercept Pharmaceuticals Key News & Latest Developments
7.11 NGM Biopharmaceuticals
7.11.1 NGM Biopharmaceuticals Company Summary
7.11.2 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Business Overview
7.11.3 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.11.4 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.11.5 NGM Biopharmaceuticals Key News & Latest Developments
7.12 Norgine
7.12.1 Norgine Company Summary
7.12.2 Norgine Liver Cirrhosis Therapeutics Drugs Business Overview
7.12.3 Norgine Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.12.4 Norgine Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.12.5 Norgine Key News & Latest Developments
7.13 Pharmicell
7.13.1 Pharmicell Company Summary
7.13.2 Pharmicell Liver Cirrhosis Therapeutics Drugs Business Overview
7.13.3 Pharmicell Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.13.4 Pharmicell Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.13.5 Pharmicell Key News & Latest Developments
7.14 Salix Pharmaceuticals
7.14.1 Salix Pharmaceuticals Company Summary
7.14.2 Salix Pharmaceuticals Business Overview
7.14.3 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.14.4 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.14.5 Salix Pharmaceuticals Key News & Latest Developments
7.15 Stempeutics Research
7.15.1 Stempeutics Research Company Summary
7.15.2 Stempeutics Research Business Overview
7.15.3 Stempeutics Research Liver Cirrhosis Therapeutics Drugs Major Product Offerings
7.15.4 Stempeutics Research Liver Cirrhosis Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.15.5 Stempeutics Research Key News & Latest Developments
8 Global Liver Cirrhosis Therapeutics Drugs Production Capacity, Analysis
8.1 Global Liver Cirrhosis Therapeutics Drugs Production Capacity, 2019-2031
8.2 Liver Cirrhosis Therapeutics Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Liver Cirrhosis Therapeutics Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Liver Cirrhosis Therapeutics Drugs Supply Chain Analysis
10.1 Liver Cirrhosis Therapeutics Drugs Industry Value Chain
10.2 Liver Cirrhosis Therapeutics Drugs Upstream Market
10.3 Liver Cirrhosis Therapeutics Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Liver Cirrhosis Therapeutics Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Liver Cirrhosis Therapeutics Drugs in Global Market
Table 2. Top Liver Cirrhosis Therapeutics Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Liver Cirrhosis Therapeutics Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Liver Cirrhosis Therapeutics Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Liver Cirrhosis Therapeutics Drugs Sales by Companies, (K Pcs), 2019-2024
Table 6. Global Liver Cirrhosis Therapeutics Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Liver Cirrhosis Therapeutics Drugs Price (2019-2024) & (USD/Pcs)
Table 8. Global Manufacturers Liver Cirrhosis Therapeutics Drugs Product Type
Table 9. List of Global Tier 1 Liver Cirrhosis Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liver Cirrhosis Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Global Liver Cirrhosis Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Liver Cirrhosis Therapeutics Drugs Revenue (US$, Mn), 2024-2031
Table 14. By Type - Global Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), 2019-2024
Table 15. By Type - Global Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), 2024-2031
Table 16. By Application ? Global Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Table 17. By Application - Global Liver Cirrhosis Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Liver Cirrhosis Therapeutics Drugs Revenue (US$, Mn), 2024-2031
Table 19. By Application - Global Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), 2019-2024
Table 20. By Application - Global Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), 2024-2031
Table 21. By Region ? Global Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2022 VS 2031
Table 22. By Region - Global Liver Cirrhosis Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Liver Cirrhosis Therapeutics Drugs Revenue (US$, Mn), 2024-2031
Table 24. By Region - Global Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), 2019-2024
Table 25. By Region - Global Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), 2024-2031
Table 26. By Country - North America Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 28. By Country - North America Liver Cirrhosis Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 29. By Country - North America Liver Cirrhosis Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 30. By Country - Europe Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 32. By Country - Europe Liver Cirrhosis Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 33. By Country - Europe Liver Cirrhosis Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 34. By Region - Asia Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 36. By Region - Asia Liver Cirrhosis Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 37. By Region - Asia Liver Cirrhosis Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 38. By Country - South America Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 40. By Country - South America Liver Cirrhosis Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 41. By Country - South America Liver Cirrhosis Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 42. By Country - Middle East & Africa Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 44. By Country - Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 45. By Country - Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 46. Gilead Sciences Company Summary
Table 47. Gilead Sciences Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 48. Gilead Sciences Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 49. Gilead Sciences Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 52. GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 56. Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 60. Merck Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 61. Merck Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 64. Roche Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 65. Roche Key News & Latest Developments
Table 66. Bristol-Myers Squibb Company Summary
Table 67. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 68. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 69. Bristol-Myers Squibb Key News & Latest Developments
Table 70. Conatus Pharmaceuticals Company Summary
Table 71. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 72. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 73. Conatus Pharmaceuticals Key News & Latest Developments
Table 74. Gwo Xi Stem Cell Applied Technology Company Summary
Table 75. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 76. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 77. Gwo Xi Stem Cell Applied Technology Key News & Latest Developments
Table 78. Instituto Grifols Company Summary
Table 79. Instituto Grifols Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 80. Instituto Grifols Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 81. Instituto Grifols Key News & Latest Developments
Table 82. Intercept Pharmaceuticals Company Summary
Table 83. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 84. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 85. Intercept Pharmaceuticals Key News & Latest Developments
Table 86. NGM Biopharmaceuticals Company Summary
Table 87. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 88. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 89. NGM Biopharmaceuticals Key News & Latest Developments
Table 90. Norgine Company Summary
Table 91. Norgine Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 92. Norgine Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 93. Norgine Key News & Latest Developments
Table 94. Pharmicell Company Summary
Table 95. Pharmicell Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 96. Pharmicell Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 97. Pharmicell Key News & Latest Developments
Table 98. Salix Pharmaceuticals Company Summary
Table 99. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 100. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 101. Salix Pharmaceuticals Key News & Latest Developments
Table 102. Stempeutics Research Company Summary
Table 103. Stempeutics Research Liver Cirrhosis Therapeutics Drugs Product Offerings
Table 104. Stempeutics Research Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 105. Stempeutics Research Key News & Latest Developments
Table 106. Liver Cirrhosis Therapeutics Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2024 (K Pcs)
Table 107. Global Liver Cirrhosis Therapeutics Drugs Capacity Market Share of Key Manufacturers, 2021-2024
Table 108. Global Liver Cirrhosis Therapeutics Drugs Production by Region, 2019-2024 (K Pcs)
Table 109. Global Liver Cirrhosis Therapeutics Drugs Production by Region, 2024-2031 (K Pcs)
Table 110. Liver Cirrhosis Therapeutics Drugs Market Opportunities & Trends in Global Market
Table 111. Liver Cirrhosis Therapeutics Drugs Market Drivers in Global Market
Table 112. Liver Cirrhosis Therapeutics Drugs Market Restraints in Global Market
Table 113. Liver Cirrhosis Therapeutics Drugs Raw Materials
Table 114. Liver Cirrhosis Therapeutics Drugs Raw Materials Suppliers in Global Market
Table 115. Typical Liver Cirrhosis Therapeutics Drugs Downstream
Table 116. Liver Cirrhosis Therapeutics Drugs Downstream Clients in Global Market
Table 117. Liver Cirrhosis Therapeutics Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Liver Cirrhosis Therapeutics Drugs Segment by Type in 2022
Figure 2. Liver Cirrhosis Therapeutics Drugs Segment by Application in 2022
Figure 3. Global Liver Cirrhosis Therapeutics Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Liver Cirrhosis Therapeutics Drugs Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Liver Cirrhosis Therapeutics Drugs Revenue, 2019-2031 (US$, Mn)
Figure 7. Liver Cirrhosis Therapeutics Drugs Sales in Global Market: 2019-2031 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Liver Cirrhosis Therapeutics Drugs Revenue in 2022
Figure 9. By Type - Global Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 10. By Type - Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 11. By Type - Global Liver Cirrhosis Therapeutics Drugs Sales Market Share, 2019-2031
Figure 12. By Type - Global Liver Cirrhosis Therapeutics Drugs Price (USD/Pcs), 2019-2031
Figure 13. By Application - Global Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 14. By Application - Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 15. By Application - Global Liver Cirrhosis Therapeutics Drugs Sales Market Share, 2019-2031
Figure 16. By Application - Global Liver Cirrhosis Therapeutics Drugs Price (USD/Pcs), 2019-2031
Figure 17. By Region - Global Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 18. By Region - Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share, 2019 VS 2022 VS 2031
Figure 19. By Region - Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 20. By Region - Global Liver Cirrhosis Therapeutics Drugs Sales Market Share, 2019-2031
Figure 21. By Country - North America Liver Cirrhosis Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 22. By Country - North America Liver Cirrhosis Therapeutics Drugs Sales Market Share, 2019-2031
Figure 23. US Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 24. Canada Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 25. Mexico Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 26. By Country - Europe Liver Cirrhosis Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 27. By Country - Europe Liver Cirrhosis Therapeutics Drugs Sales Market Share, 2019-2031
Figure 28. Germany Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 29. France Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 30. U.K. Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 31. Italy Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 32. Russia Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 33. Nordic Countries Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 34. Benelux Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 35. By Region - Asia Liver Cirrhosis Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 36. By Region - Asia Liver Cirrhosis Therapeutics Drugs Sales Market Share, 2019-2031
Figure 37. China Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 38. Japan Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 39. South Korea Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 40. Southeast Asia Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 41. India Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 42. By Country - South America Liver Cirrhosis Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 43. By Country - South America Liver Cirrhosis Therapeutics Drugs Sales Market Share, 2019-2031
Figure 44. Brazil Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 45. Argentina Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 46. By Country - Middle East & Africa Liver Cirrhosis Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 47. By Country - Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales Market Share, 2019-2031
Figure 48. Turkey Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 49. Israel Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 50. Saudi Arabia Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 51. UAE Liver Cirrhosis Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 52. Global Liver Cirrhosis Therapeutics Drugs Production Capacity (K Pcs), 2019-2031
Figure 53. The Percentage of Production Liver Cirrhosis Therapeutics Drugs by Region, 2022 VS 2031
Figure 54. Liver Cirrhosis Therapeutics Drugs Industry Value Chain
Figure 55. Marketing Channels
